Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (211-220 of 509) with videos related to

Pageof 51
Sort By:
Plos One|May 30, 2013
High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, RwandaJohn Rusine, Pascale Ondoa, Brenda Asiimwe-Kateera, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophyMarit G A van Vonderen, Yvo M Smulders, Coen D A Stehouwer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapyWilliam Worodria, Marguerite Massinga-Loembe, Doreen Mazakpwe, et al.
ACS Nano|September 6, 2011
Cell-permeable Ln(III) chelate-functionalized InP quantum dots as multimodal imaging agentsGraeme J Stasiuk, Sudarsan Tamang, Daniel Imbert, et al.
Scientific Reports|January 16, 2015
Enhanced charge separation in ternary P3HT/PCBM/CuInS2 nanocrystals hybrid solar cellsAurélie Lefrançois, Beata Luszczynska, Brigitte Pepin-Donat, et al.
Circulation|June 21, 2008
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factorsCarl Grunfeld, Donald P Kotler, Donna K Arnett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D studyMathias Bruyand, Lene Ryom, Leah Shepherd, et al.
Drugs - Real World Outcomes|July 12, 2016
Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIVEsther A N Engelhard, Colette Smit, Sigrid C J M Vervoort, et al.
Antiviral Therapy|February 5, 2008
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimenReshma S Autar, Mark A Boyd, Ferdinand W M N Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2012
Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapyMadeleine J Bunders, Olivier Frinking, Henriette J Scherpbier, et al.
Pageof 51

Showing results (211-220 of 509) with videos related to

Sort By:
Pageof 51
Plos One|May 30, 2013
High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, RwandaJohn Rusine, Pascale Ondoa, Brenda Asiimwe-Kateera, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophyMarit G A van Vonderen, Yvo M Smulders, Coen D A Stehouwer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2011
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapyWilliam Worodria, Marguerite Massinga-Loembe, Doreen Mazakpwe, et al.
ACS Nano|September 6, 2011
Cell-permeable Ln(III) chelate-functionalized InP quantum dots as multimodal imaging agentsGraeme J Stasiuk, Sudarsan Tamang, Daniel Imbert, et al.
Scientific Reports|January 16, 2015
Enhanced charge separation in ternary P3HT/PCBM/CuInS2 nanocrystals hybrid solar cellsAurélie Lefrançois, Beata Luszczynska, Brigitte Pepin-Donat, et al.
Circulation|June 21, 2008
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factorsCarl Grunfeld, Donald P Kotler, Donna K Arnett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D studyMathias Bruyand, Lene Ryom, Leah Shepherd, et al.
Drugs - Real World Outcomes|July 12, 2016
Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIVEsther A N Engelhard, Colette Smit, Sigrid C J M Vervoort, et al.
Antiviral Therapy|February 5, 2008
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimenReshma S Autar, Mark A Boyd, Ferdinand W M N Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2012
Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapyMadeleine J Bunders, Olivier Frinking, Henriette J Scherpbier, et al.
Pageof 51